E

Aequus Pharmaceuticals Inc. AQSZF

$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Day's Range
$0.00$0.00
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

AQSZF Rating

Reward
Risk

AQSZF Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

AQSZF Company Overview

Aequus Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company focused on acquiring, in-licensing, and commercializing prescription products that address unmet medical needs. The company operates primarily within the pharmaceuticals and healthcare industry, with an emphasis on niche therapeutic areas where it can leverage targeted sales, regulatory expertise, and partner-driven development. Its business model centers on late-stage or already-approved products, reducing early-stage development risk.

The company was incorporated in 2013 and is headquartered in Vancouver, Canada. Since inception, Aequus has evolved from an early-stage specialty pharma company into a commercial-stage organization with a portfolio strategy based on regional licensing, co-development, and commercialization partnerships. Its positioning is defined by a capital-efficient approach, reliance on external manufacturing and development partners, and a focus on products with defined regulatory pathways.

Data compiled by narrative technology. May contain errors.
Sector

AQSZF Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

AQSZF Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

AQSZF Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

AQSZF Price History

Loading...
52-Week Range1% of range
Current
$0.00
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

AQSZF Valuation

Market Cap
Market Cap Rank
#18,640
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

AQSZF Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

AQSZF Corporate Info

Phone Number
604 336 7906
Address
200 Granville Street
Suite 2820
Vancouver, BC V6C 1S4
Country
Year Founded

AQSZF Filings

Filing Date
Friday, November 28, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
(est)

AQSZF Headlines

There are no news to display.